185 related articles for article (PubMed ID: 31406249)
1. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.
Bhoopathi P; Pradhan AK; Bacolod MD; Emdad L; Sarkar D; Das SK; Fisher PB
Oncogene; 2019 Oct; 38(41):6781-6793. PubMed ID: 31406249
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
3. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
[TBL] [Abstract][Full Text] [Related]
4. MDA-9/syntenin is a key regulator of glioma pathogenesis.
Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
[TBL] [Abstract][Full Text] [Related]
5. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
[TBL] [Abstract][Full Text] [Related]
6. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
[TBL] [Abstract][Full Text] [Related]
7. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.
Dasgupta S; Menezes ME; Das SK; Emdad L; Janjic A; Bhatia S; Mukhopadhyay ND; Shao C; Sarkar D; Fisher PB
Clin Cancer Res; 2013 Sep; 19(17):4621-33. PubMed ID: 23873690
[TBL] [Abstract][Full Text] [Related]
8. SENP1 regulates cell migration and invasion in neuroblastoma.
Xiang-Ming Y; Zhi-Qiang X; Ting Z; Jian W; Jian P; Li-Qun Y; Ming-Cui F; Hong-Liang X; Xu C; Yun Z
Biotechnol Appl Biochem; 2016 May; 63(3):435-40. PubMed ID: 25816890
[TBL] [Abstract][Full Text] [Related]
9. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
[TBL] [Abstract][Full Text] [Related]
12. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
13. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
14. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
[TBL] [Abstract][Full Text] [Related]
15. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
16. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
17. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
18. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
[TBL] [Abstract][Full Text] [Related]
19. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
20. Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.
Wu L; Bernard-Trifilo JA; Lim Y; Lim ST; Mitra SK; Uryu S; Chen M; Pallen CJ; Cheung NK; Mikolon D; Mielgo A; Stupack DG; Schlaepfer DD
Oncogene; 2008 Feb; 27(10):1439-48. PubMed ID: 17828307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]